Trials / Completed
CompletedNCT05164003
CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase1)
A Randomized, Double-blind, Active Drug Controlled, Multi-Center, Phase I/III Clinical Trial to Evaluate the Efficacy and Safety of CORETOX® in Treatment of Post Stroke Upper Limb Spasticity
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Medy-Tox · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and pharmacodynamic of CORETOX® in the treatment of post-stroke upper limb spasticity
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CORETOX® | Up to a total of 360U of the IP was allowed to be injected at three flexors; wrist, elbow and finger. |
| DRUG | BOTOX® | Up to a total of 360U of the comparator was allowed to be injected at three flexors; wrist, elbow and finger. |
Timeline
- Start date
- 2017-07-17
- Primary completion
- 2017-09-29
- Completion
- 2017-09-29
- First posted
- 2021-12-20
- Last updated
- 2022-01-11
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05164003. Inclusion in this directory is not an endorsement.